YOKNEAM, Israel, March 3, 2014 /PRNewswire/ -- Syneron
Medical Ltd. (NASDAQ:ELOS), the leading global aesthetic device
company, announced today that Hugo
Goldman, Chief Financial Officer, is scheduled to present at
the Barclays Global Healthcare Conference in Miami, FL. This conference will allow
institutional investors to meet with the Company and includes a
formal presentation.
Conference:
|
Barclays Global
Healthcare Conference
|
Date:
|
Wednesday, March 12,
2014
|
Time:
|
8:30 am ET
|
The presentation will be webcast live over the Internet and can
be accessed through the Investor Relations section on Syneron's
website at www.investors.syneron.com. Please go to the website a
few minutes early, as it may be necessary to download audio
software to hear the presentations.
About Syneron Medical Ltd.
Syneron Medical Ltd.
(NASDAQ: ELOS) is the leading global aesthetic device company with
a comprehensive product portfolio and a global distribution
footprint. The Company's technology enables physicians to provide
advanced solutions for a broad range of medical-aesthetic
applications including body contouring, hair removal, wrinkle
reduction, rejuvenation of the skin's appearance through the
treatment of superficial benign vascular and pigmented lesions, and
the treatment of acne, leg veins and cellulite. The Company sells
its products under two distinct brands, Syneron and Candela.
Founded in 2000, the corporate, R&D, and manufacturing
headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and
manufacturing operations in the US. The Company markets and
services and supports its products in 90 countries. It has offices
in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan,
and Hong Kong and distributors
worldwide.
Logo - http://photos.prnewswire.com/prnh/20120528/535447
SOURCE Syneron Medical Ltd.